Ascension Healthcare plc Announces Distribution Agreement with Apex
LONDON, December 3, 2019 Ascension Healthcare plc (Ascension or the Company), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis, today announces it has signed an important distribution agreement with Apex Pharma Marketing Pte Ltd, Singapore and Apex Pharmacy Marketing Sdn Bhd, Malaysia (collectively referred to as Apex) to supply Flexiseq to the Singapore and Malaysian markets.
- LONDON, December 3, 2019 Ascension Healthcare plc (Ascension or the Company), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis, today announces it has signed an important distribution agreement with Apex Pharma Marketing Pte Ltd, Singapore and Apex Pharmacy Marketing Sdn Bhd, Malaysia (collectively referred to as Apex) to supply Flexiseq to the Singapore and Malaysian markets.
- Apex are wholly owned subsidiaries of Apex Healthcare Berhad, which is publicly listed on the Malaysian stock exchange.
- Under the terms of the agreement, Apex will purchase Flexiseq products from Ascension and be the exclusive importers and distributors over a two-year period, to service the pharmacy market, including A.S. Watsons, Guardian and Caring Pharmacy chains in the region.
- Biresh Roy, Chief Executive Officer of Ascension, said: There is a growing need for safe alternatives to treat osteoarthritis.